Despite soaring global demand for healthcare, the challenge of profitably developing treatments has never been greater or more ethically complex. Can pharma giants strike the right balance?
Recent insights
3 3月 2020
A General Safety Provision - are we there yet??
10 2月 2020
Patent and Pharma Update, February 2020
6 2月 2020
Australian privacy law reform and review announced
6 2月 2020
ECJ rules for the first time on “pay-for-delay” agreements
30 1月 2020
Unfolding privacy class actions in Australia
11 12月 2019
Big data is transforming investigations
10 12月 2019
The ACCC pilots its first ‘effect test’ in misuse of market power proceedings
5 12月 2019
The ACCC continues its push on personal information
22 10月 2019
Patent and Pharma Update, October 2019
12 9月 2019
ACCC issues guidance on competition risks in IP transactions: Beware the inadvertent cartel
5 9月 2019
Industry engagement essential to success of ‘gateway’ model for energy sector CDR
30 8月 2019
The Rise of Super Apps in Indonesia
